Literature DB >> 20012411

Murine model of polymicrobial septic peritonitis using cecal ligation and puncture (CLP).

Eva Medina1.   

Abstract

Although a number of animal models such as endotoxic shock and bacteremia have been used to study the pathogenesis of sepsis, cecal ligation and puncture (CLP) represents a peritonitis model with clinical features of polymicrobial infection comparable with those of peritonitis in humans. The CLP consists in the surgical perforation of the legated cecum of mice that results in immediate and constant drainage of cecal bacteria into the peritoneal cavity. The severity of the diseases depends on the diameter of the needle used for the perforation as well as on the number of cecal punctures. The CLP model of sepsis in mice is the most commonly used for studying the process of septic peritonitis and can be used as a preclinical model to test the efficacy of pharmacological agents for the treatment of sepsis.

Entities:  

Mesh:

Year:  2010        PMID: 20012411     DOI: 10.1007/978-1-60761-058-8_23

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

1.  Contributing factors in the development of acute lung injury in a murine double hit model.

Authors:  Philipp Störmann; Nils Becker; Leander Künnemeyer; Sebastian Wutzler; Jan Tilmann Vollrath; Thomas Lustenberger; Frank Hildebrand; Ingo Marzi; Borna Relja
Journal:  Eur J Trauma Emerg Surg       Date:  2019-04-01       Impact factor: 3.693

2.  Adoptive transfer of bone marrow-derived dendritic cells decreases inhibitory and regulatory T-cell differentiation and improves survival in murine polymicrobial sepsis.

Authors:  Hong-Wei Wang; Wen Yang; Lei Gao; Jia-Rui Kang; Jia-Jian Qin; Yue-Ping Liu; Jiang-Yang Lu
Journal:  Immunology       Date:  2015-05       Impact factor: 7.397

3.  The hydroxylase inhibitor dimethyloxallyl glycine attenuates endotoxic shock via alternative activation of macrophages and IL-10 production by B1 cells.

Authors:  Emily Hams; Sean P Saunders; Eoin P Cummins; Aisling O'Connor; Murtaza T Tambuwala; William M Gallagher; Annette Byrne; Antonio Campos-Torres; Paul M Moynagh; Christian Jobin; Cormac T Taylor; Padraic G Fallon
Journal:  Shock       Date:  2011-09       Impact factor: 3.454

4.  Hepatic FGF21 preserves thermoregulation and cardiovascular function during bacterial inflammation.

Authors:  Sarah C Huen; Andrew Wang; Kyle Feola; Reina Desrouleaux; Harding H Luan; Richard Hogg; Cuiling Zhang; Qing-Jun Zhang; Zhi-Ping Liu; Ruslan Medzhitov
Journal:  J Exp Med       Date:  2021-08-18       Impact factor: 14.307

5.  Exogenous carbon monoxide attenuates inflammatory responses in the small intestine of septic mice.

Authors:  Xu Wang; Jie Cao; Bing-Wei Sun; Da-Dong Liu; Feng Liang; Liang Gao
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

6.  Humanized FcRn mouse models for evaluating pharmacokinetics of human IgG antibodies.

Authors:  Gabriele Proetzel; Derry C Roopenian
Journal:  Methods       Date:  2013-07-16       Impact factor: 3.608

7.  Changes in CRH and ACTH synthesis during experimental and human septic shock.

Authors:  Andrea Polito; Romain Sonneville; Céline Guidoux; Lucinda Barrett; Odile Viltart; Virginie Mattot; Shidasp Siami; Geoffroy Lorin de la Grandmaison; Fabrice Chrétien; Mervyn Singer; Françoise Gray; Djillali Annane; Jean-Philippe Brouland; Tarek Sharshar
Journal:  PLoS One       Date:  2011-11-03       Impact factor: 3.240

8.  The effect of ghrelin upon the early immune response in lean and obese mice during sepsis.

Authors:  Daniel Siegl; Emily F Midura; Thorsten Annecke; Peter Conzen; Charles C Caldwell; Johannes Tschoep
Journal:  PLoS One       Date:  2015-04-06       Impact factor: 3.240

9.  Pathophysiological Approaches of Acute Respiratory Distress syndrome: Novel Bases for Study of Lung Injury.

Authors:  R L Castillo; R Carrasco Loza; C Romero-Dapueto
Journal:  Open Respir Med J       Date:  2015-06-26

Review 10.  CD1d- and MR1-Restricted T Cells in Sepsis.

Authors:  Peter A Szabo; Ram V Anantha; Christopher R Shaler; John K McCormick; S M Mansour Haeryfar
Journal:  Front Immunol       Date:  2015-08-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.